Honolulu Heart Program (HHP) - Catalog
Honolulu Heart Program (HHP)
HLB00070023a
HHP
HHS
False
True
True
Coded
False
Epidemiology Study
Open BioLINCC Study
Adult
2009-10-01
2010-09-24
2008-10-13
2005-06-23
1965-1998
DCVS
Heart
non-HIV
non-COVID
1876
0
No
No
No
No
Yes
No
Aortic Aneurysm, Abdominal
Asthma
Bronchitis
Cardiovascular Diseases
Cerebrovascular Accident
Chronic Obstructive Pulmonary Disease
Coronary Disease
Dementia
Emphysema
Heart Diseases
Heart Failure
Heart Failure, Congestive
Hypertension
Lung Diseases, Obstructive
Myocardial Infarction
The initial objectives of the Honolulu Heart Program were to: 1) estimate morbidity and mortality from coronary heart disease and stroke among Japanese men in Honolulu; 2) compare morbidity and mortality from coronary heart disease and stroke among Japanese men in Japan, Honolulu, and San Francisco; 3) investigate relationships among risk factors, coronary heart disease, and stroke in Japanese men in Honolulu; 4) compare distributions of risk factors among men in Japan, Honolulu, and San Francisco, and relate similarities and differences in risk factors to the occurrence of disease in these areas and in other populations, including Framingham and Puerto Rico; 5) conduct an autopsy study, and to relate pathological findings to morbidity and mortality data; and 6) investigate relationships between risk factors and pathological evidence of atherosclerosis and its complications.
The Honolulu Heart Program was initiated in 1965 by the NHLBI as a prospective study of environmental and biological causes of cardiovascular disease among Japanese Americans living in Hawaii. This population was known to have low incidence of coronary heart disease and higher incidence of stroke. The study provided opportunities to investigate relationships among disease frequencies, pathologic findings, and disease predictors in the cohort and to compare the findings in this population with those in other populations, especially cohorts of Japanese men resident in Japan or the U.S.
American men of Japanese ancestry born in 1900-1919 and living on the island of Oahu in 1965; age at entry 28-62 years; sample size: 8,006.
The study began in 1965 with the first examination of a cohort of 8,006 Japanese-American men residing on the island of Oahu, Hawaii who were born during the period 1900-1919. The first examination was completed in 1968 and was followed by the initiation of a second examination that same year. Three subsequent sub-examinations (Lipoprotein Exams I, II and III) were conducted between 1970 and 1982 to collect lipid measurements on a subset of those who participated in Exam 2. The fourth examination of surviving members of the original cohort was conducted during 1991-93 and collected data on 3,741 men. Morbidity and mortality follow-up continues through grant and contract-supported efforts, and the current HHP dataset includes events through 1998.
DNA
Plasma
Serum
The study population available in BioLINCC study data may be lower than total study enrollment due to Informed Consent restrictions and other factors.
-
Subjects
8008
Last Modified: July 28, 2014, 3:44 p.m. -
Age
N
%
Unknown
2
0.02
45 -< 50
1859
23.21
50 -< 55
2775
34.65
55 -< 60
1593
19.89
60 -< 65
1336
16.68
65 -< 70
443
5.53
Last Modified: March 7, 2016, 4:33 p.m. -
Sex
Male
Last Modified: July 28, 2014, 3:48 p.m. -
Race
Japanese-American
Last Modified: July 28, 2014, 3:48 p.m.
Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3 of the BioLINCC handbook describes the components of the review process
-
Material Types
-
General Freeze/Thaw Status
-
Visits (Vials)
03/08/2021
Last Modified: March 8, 2021, 4:29 p.m. -
Visits (Subjects)
03/08/2021
Serum Total number of subjects Average volume (ml) per subject Examination 2 2,812 3.71 Examination 3 5,207 1.84 Examination 4 3,500 3.88 Kittner Study 1,434 3.71 Lipoproteins Examination 1 1,398 5.71 Lipoproteins Examination 2 2,361 9.01 Lipoproteins Examination 3 24 1.60 Unknown 488 10.16 Plasma Total number of subjects Average volume (ml) per subject Examination 2 32 4.18 Examination 4 3,614 5.54 Lipoproteins Examination 1 1,059 3.86 Lipoproteins Examination 3 1,740 3.37 Unknown 575 0.87 DNA Total number of subjects Average mass (µg) per subject Average vials per subject Examination 4 2,322 14.52 4.67
Last Modified: March 8, 2021, 4:29 p.m.